Trupanion (NASDAQ:TRUP) COO John Gallagher Sells 3,604 Shares

Trupanion, Inc. (NASDAQ:TRUP) COO John Gallagher sold 3,604 shares of the business’s stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $29.70, for a total value of $107,038.80. Following the completion of the transaction, the chief operating officer owned 33,742 shares of the company’s stock, valued at $1,002,137.40. This represents a 9.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trupanion Stock Performance

Shares of TRUP stock opened at $27.88 on Wednesday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. The company has a market capitalization of $1.22 billion, a P/E ratio of 52.60, a price-to-earnings-growth ratio of 1.97 and a beta of 1.45. The company’s 50 day moving average price is $27.21 and its two-hundred day moving average price is $25.89. Trupanion, Inc. has a 52 week low of $21.16 and a 52 week high of $46.98.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.05. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The company had revenue of $392.93 million during the quarter, compared to analysts’ expectations of $389.72 million. During the same quarter in the prior year, the company earned $0.22 earnings per share. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. On average, analysts expect that Trupanion, Inc. will post 0.63 earnings per share for the current fiscal year.

Institutional Trading of Trupanion

A number of institutional investors and hedge funds have recently made changes to their positions in TRUP. Kelleher Financial Advisors bought a new stake in Trupanion during the second quarter worth $42,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Trupanion during the fourth quarter valued at about $64,000. Parallel Advisors LLC boosted its position in Trupanion by 1,831.9% during the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after buying an additional 1,722 shares during the period. Quantbot Technologies LP bought a new stake in shares of Trupanion in the second quarter worth $89,000. Finally, Advisory Services Network LLC bought a new stake in shares of Trupanion in the 3rd quarter valued at about $160,000.

Wall Street Analyst Weigh In

TRUP has been the subject of a number of recent research reports. Piper Sandler downgraded Trupanion from an “overweight” rating to a “neutral” rating and reduced their price target for the stock from $45.00 to $32.00 in a research report on Wednesday, August 26th. Atlantic Securities set a $42.00 price target on Trupanion in a report on Wednesday, July 15th. Stifel Nicolaus upped their price objective on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a report on Thursday, August 20th. Weiss Ratings raised Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, August 26th. Finally, Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 24th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Trupanion has a consensus rating of “Hold” and an average price target of $39.20.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.